ReviewNutrients2022

Remission as an Emerging Therapeutic Target in Type 2 Diabetes in the Era of New Glucose-Lowering Agents: Benefits, Challenges, and Treatment Approaches.

Dimitra Vasdeki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.